ZME Science
No Result
View All Result
ZME Science
No Result
View All Result
ZME Science

Home → Science

A compound against SARS shows promise against the COVID-19 virus

"Striking similarities" between the two viruses make them vulnerable to the same compounds.

Alexandru MicubyAlexandru Micu
March 9, 2020
in Biology, Health, News, Science
A A
Share on FacebookShare on TwitterSubmit to Reddit

Commonalities between the coronavirus responsible for the current outbreak and the SARS virus could point the way towards a treatment option, a new paper reports.

Graphical abstract of the study.
Image credits Hoffman et al., (2020), Cell.

SARS (severe acute respiratory syndrome) was capturing headlines and causing panic around the world back in 2003. The virus responsible for SARS — SARS-CoV — is a coronavirus related to the current SARS-CoV-2 virus that is at the root of the current global outbreak. SARS eventually resulted in more than 8,000 cases and 800 deaths, but was contained through a combination of “surveillance, prompt isolation of patients, strict enforcement of quarantine of all contacts, and in some areas top-down enforcement of community quarantine,” according to a study (A. Wilder-Smith, J. Chiew, J. Lee, 2020) published last week in The Lancet.

“By interrupting all human-to-human transmission, SARS was effectively eradicated. By contrast, by Feb 28, 2020, within a matter of 2 months since the beginning of the outbreak of coronavirus disease 2019 (COVID-19), more than 82,000 confirmed cases of COVID-19 have been reported with more than 2,800 deaths,” the study adds.

“Although there are striking similarities between SARS and COVID-19, the differences in the virus characteristics will ultimately determine whether the same measures for SARS will also be successful for COVID-19.”

The “striking similarities” the authors note here may, however, point us to a viable treatment option for the COVID-19 disease caused by the SARS-CoV-2 virus.

Birds of a feather get shot together

Published in the journal Cell, the new study explains that structural similarities between the two viruses allow for a substance already approved for clinical use against SARS to engage the COVID-19 virus and that natural antibodies against SARS “may offer some protection” against the current outbreak.

“A TMPRSS2 inhibitor approved for clinical use blocked entry and might constitute a treatment option,” the authors explain. “Finally, we show that the sera from convalescent SARS patients cross-neutralized SARS-2-S-driven entry. Our results reveal important commonalities between [the two viruses] and identify a potential target for antiviral intervention.”

TMPRSS2, or transmembrane protease serine 2, is an enzyme (protein) in the serine protease family that “is associated with […] processes such as digestion, tissue remodeling, blood coagulation, fertility, inflammatory responses, tumor cell invasion, and apoptosis [cellular death],” according to Sciencedirect. According to the findings, the COVID-19 virus relies on this enzyme to reproduce (by multiplying its genes inside infected cells). The authors further report that the virus enters human cells by using ACE2 (angiotensin converting enzyme 2) receptors on its viral casing.

This process is the same one used by the SARS virus. A more exciting finding was that a TMPRSS2-inhibiting compound already approved for use against SARS successfully prevented the COVID-19 virus from infecting human cells. In addition, the team found that serum derived from the blood of former SARS patients — which contains natural antibodies against it — is “moderately effective” in protecting individuals from infection with the COVID-19 virus.

“Although confirmation with infectious virus is pending, our results indicate that neutralizing antibody responses raised against SARS-S could offer some protection against SARS-CoV-2 infection, which may have implications for outbreak control,” they explain.

While the findings are definitely encouraging, there are still unknowns left to sort out. For example, the higher infection rates seen in COVID-19 compared to SARS could mean that the new coronavirus is better able to bind to the ACE2 receptors in cells in the upper respiratory tract. More research is needed, and fast, to elucidate these issues, the team explains, but they are hopeful that their findings lay the groundwork for such efforts in the future.

RelatedPosts

Covid-19 smell loss is “much more profound” than common cold or flu
French study calls for nicotine patch trial against COVID-19
Only around 6% of coronavirus infections worldwide are detected so far, German researchers estimate
US scientists say light can kill coronavirus, but no paper published just yet

The paper “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor” has been published in the journal Cell.

Tags: coronavirusoutbreakpreventionSARS

ShareTweetShare
Alexandru Micu

Alexandru Micu

Stunningly charming pun connoisseur, I have been fascinated by the world around me since I first laid eyes on it. Always curious, I'm just having a little fun with some very serious science.

Related Posts

Diseases

Mysterious “Disease X” identified as aggressive strain of malaria

byMihai Andrei
5 months ago
Health

Parvovirus B19: CDC warns of new “slapped cheek disease” uptick

byAlexandra Gerea
9 months ago
Diseases

FLiRT and FLuQE, the new COVID variants making the rounds

byMihai Andrei
10 months ago
Diseases

Moderna’s flu + Covid jab produces “higher immune response” than two separate shots

byMihai Andrei
11 months ago

Recent news

A Swedish Library Forgot to Close Its Doors and Something Beautiful Happened

May 21, 2025

Scientists Found a Neanderthal Population That Lived in Total Isolation for 50,000 Years

May 21, 2025

Doctors Warn That Bringing Your Phone to the Bathroom Could Backfire in a Painful Way

May 21, 2025
  • About
  • Advertise
  • Editorial Policy
  • Privacy Policy and Terms of Use
  • How we review products
  • Contact

© 2007-2025 ZME Science - Not exactly rocket science. All Rights Reserved.

No Result
View All Result
  • Science News
  • Environment
  • Health
  • Space
  • Future
  • Features
    • Natural Sciences
    • Physics
      • Matter and Energy
      • Quantum Mechanics
      • Thermodynamics
    • Chemistry
      • Periodic Table
      • Applied Chemistry
      • Materials
      • Physical Chemistry
    • Biology
      • Anatomy
      • Biochemistry
      • Ecology
      • Genetics
      • Microbiology
      • Plants and Fungi
    • Geology and Paleontology
      • Planet Earth
      • Earth Dynamics
      • Rocks and Minerals
      • Volcanoes
      • Dinosaurs
      • Fossils
    • Animals
      • Mammals
      • Birds
      • Fish
      • Amphibians
      • Reptiles
      • Invertebrates
      • Pets
      • Conservation
      • Animal facts
    • Climate and Weather
      • Climate change
      • Weather and atmosphere
    • Health
      • Drugs
      • Diseases and Conditions
      • Human Body
      • Mind and Brain
      • Food and Nutrition
      • Wellness
    • History and Humanities
      • Anthropology
      • Archaeology
      • History
      • Economics
      • People
      • Sociology
    • Space & Astronomy
      • The Solar System
      • Sun
      • The Moon
      • Planets
      • Asteroids, meteors & comets
      • Astronomy
      • Astrophysics
      • Cosmology
      • Exoplanets & Alien Life
      • Spaceflight and Exploration
    • Technology
      • Computer Science & IT
      • Engineering
      • Inventions
      • Sustainability
      • Renewable Energy
      • Green Living
    • Culture
    • Resources
  • Videos
  • Reviews
  • About Us
    • About
    • The Team
    • Advertise
    • Contribute
    • Editorial policy
    • Privacy Policy
    • Contact

© 2007-2025 ZME Science - Not exactly rocket science. All Rights Reserved.